ANI Pharmaceuticals, Inc.
ANIP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $26,617 | $8,549 | $15,681 | -$10,276 |
| Dep. & Amort. | $22,632 | $23,281 | $22,891 | $22,600 |
| Deferred Tax | $18,800 | -$3,536 | -$3,383 | -$17,530 |
| Stock-Based Comp. | $9,691 | $9,602 | $8,868 | $7,061 |
| Change in WC | -$17,835 | $36,236 | $1,329 | -$4,783 |
| Other Non-Cash | -$15,850 | $1,680 | -$10,395 | $18,788 |
| Operating Cash Flow | $44,055 | $75,812 | $34,991 | $15,860 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6,103 | -$4,014 | -$2,474 | -$2,394 |
| Net Acquisitions | $0 | $0 | $0 | -$8,201 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$60 | -$2,895 | -$17,372 | -$86 |
| Investing Cash Flow | -$6,163 | -$6,909 | -$19,846 | -$10,681 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,031 | -$2,031 | -$2,031 | $36,567 |
| Stock Issued | $0 | $0 | $0 | $1,700 |
| Stock Repurch. | $0 | $0 | -$10,003 | -$318 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $8,720 | $691 | $2,534 | -$42,450 |
| Financing Cash Flow | $6,345 | -$1,747 | -$9,906 | -$4,907 |
| Forex Effect | $576 | $841 | -$297 | -$395 |
| Net Chg. in Cash | $44,813 | $67,997 | $4,942 | -$123 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $217,833 | $149,836 | $144,894 | $145,017 |
| End Cash | $262,646 | $217,833 | $149,836 | $144,894 |
| Free Cash Flow | $37,892 | $68,903 | $15,145 | $13,380 |